Journal Information
Most often read
29105
Anti-hepatitis B virus activity of food nutrients and potential mechanisms of actionAlexis Jose-Abrego, Ingrid Rivera-Iñiguez, Luis A. Torres-Reyes, Sonia Roman
Ann Hepatol. 2023;28:100766
29105
Full text access
7767
Liver diseases: Perspective from the PhilippinesEric David Ornos, Karl Jeffrey Murillo, Janus P. Ong
Ann Hepatol. 2023;28:101085
7767
Full text access
7308
What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease?Ingrid Rivera-Iñiguez, Arturo Panduro, Sonia Roman, Karina González-Aldaco
Ann Hepatol. 2023;28:100874
7308
Open access
4529
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonistsLucy Gracen, Withma Muthukumara, Melanie Aikebuse, Anthony Russell, James O'Beirne, Katharine M. Irvine, Suzanne Williams, Gaurav Puri, ... Elizabeth E. Powell
Ann Hepatol. 2023;28:101142
4529
Full text access
3868
A thorny matter: Spur cell anemiaRuchi Sharma, Carol J. Holman, Kyle E. Brown
Ann Hepatol. 2023;28:100771
3868
Open access
3850
New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLDLouise Torres, Alice Schuch, Larisse Longo, Bruna Bressan Valentini, Gabriela Schneider Galvão, Eduardo Luchese, Carlos Pinzon, Rodrigo Bartels, Mário Reis Álvares-da-Silva
Ann Hepatol. 2023;28:100774
3850
Open access
3332
Intravenous albumin in cirrhosis: Updated clinical uses and novel perspectivesRoberta Gagliardi, Nicola Zeni, Salvatore Piano
Ann Hepatol. 2023;28:101150
3332
Full text access
2892
Consensus document on acute-on-chronic liver failure (ACLF) established by the Mexican Association of HepatologyAldo Torre, Laura Esthela Cisneros-Garza, Mauricio Castillo-Barradas, Nalu Navarro-Alvarez, Ricardo Sandoval-Salas, María Sarai González-Huezo, José Luís Pérez-Hernández, Osvely Méndez-Guerrero, ... Francisco Alfonso Solís-Galindo
Ann Hepatol. 2023;28:101140
2892
Full text access
2417
Immunotolerance in liver transplantation: a primer for the clinicianJuanita Pérez-Escobar, Jose Victor Jimenez, Erika Faride Rodríguez-Aguilar, Maximiliano Servín-Rojas, Jesus Ruiz-Manriquez, Luisa Safar-Boueri, Eduardo Carrillo-Maravilla, Miquel Navasa, Ignacio García-Juárez
Ann Hepatol. 2023;28:100760
2417
Open access
2303
Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agentsDiego García-Compeán, Ramesh Kumar, Ángel Noe del Cueto-Aguilera, Héctor Jesús Maldonado-Garza, Jesús Zacarías Villarreal-Pérez
Ann Hepatol. 2023;28:100751
2303
Full text access
2213
Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: Systematic review and meta-analysisDaniela Contreras, Alejandra González-Rocha, Patricia Clark, Simón Barquera, Edgar Denova-Gutiérrez
Ann Hepatol. 2023;28:100873
2213
Open access
1891
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysisMark Muthiah, Cheng Han Ng, Kai En Chan, Clarissa Elysia Fu, Wen Hui Lim, Darren Jun Hao Tan, Benjamin Nah, Gwyneth Kong, ... Mazen Noureddin
Ann Hepatol. 2023;28:100762
1891
Open access
1603
Severe anemia is associated with increased short-term and long-term mortality in patients hospitalized with cirrhosisHaotang Ren, Hai Li, Guohong Deng, Xianbo Wang, Xin Zheng, Yan Huang, Jinjun Chen, Zhongji Meng, ... Yu Shi
Ann Hepatol. 2023;28:101147
1603
Full text access
1591
Comparison of diagnostic performance of AFP, DCP and two diagnostic models in hepatocellular carcinoma: a retrospective studyYongwu Chen, Xiuli Yang, Yanfei Shao, Hongying Zhao, Jinying Jiang, Ping Huang, Yi Lu, Zixue Xuan
Ann Hepatol. 2023;28:101099
1591
Full text access
1538
The treatment of diabetes in advanced liver disease: change of a paradigmMaria Letizia Petroni, Lucia Brodosi, Giulio Marchesini
Ann Hepatol. 2023;28:100772
1538
Open access
1274
Elevated lactate/albumin ratio as a novel predictor of in-hospital mortality in hospitalized cirrhoticsItamar Krispin, Mahmud Mahamid, Eran Goldin, Bashar Fteiha
Ann Hepatol. 2023;28:100897
1274
Full text access
1273
Prevalence of liver cirrhosis based on the metabolic health and weight criteria: Report from the Korea National Health and Nutrition Examination Survey (KNHANES) data analysisHyukjin Mun, Eun Sun So
Ann Hepatol. 2023;28:100721
1273
Full text access
1213
Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver diseaseJing Liu, Haifeng Lv, Jie Wang, Qianru Zhu, Gongying Chen, Yanming Jiang, Ke Zhao, Li Shao, ... Xiaoben Pan
Ann Hepatol. 2023;28:100892
1213
Full text access
1195
Combined effects of hyponatremia and hepatic encephalopathy on inpatient mortalityMahak Chauhan, Talan Zhang, Paul J. Thuluvath
Ann Hepatol. 2023;28:101084
1195
Full text access
1181
Late evening snack and oral amino acid capsules improved respiratory quotient and Fischer ratio in patients with alcoholic liver cirrhosisJuan Zhao, Jing Wu, Juan Li, Zhong-Ying Wang, Qing-Hua Meng
Ann Hepatol. 2023;28:100750
1181
Full text access